10936886|t|Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.
10936886|a|Amyloid beta-protein (Abeta), the major component of plaques in Alzheimer's disease, is a small hydrophobic protein that is carried on apolipoprotein E (ApoE)- and ApoJ-containing lipoprotein particles in plasma and cerebrospinal fluid (CSF). Microglia, the scavenger cells of the CNS, take up and degrade Abeta via lipoprotein receptors including scavenger receptors A and B, and possibly via other receptors. Lipoproteins, ApoE, and ApoJ influence the uptake and degradation of Abeta in vitro and in vivo. Differences in ApoE-E4, -E3, and -E2 isoforms with respect to Abeta binding to lipoproteins and delivery to cells, including microglia, may contribute to the increased risk of Alzheimer's disease for people with an APOE4 genotype and to risk reduction with APOE2.
10936886	55	66	Alzheimer's	Disease	MESH:D000544
10936886	111	116	Abeta	Gene	351
10936886	153	172	Alzheimer's disease	Disease	MESH:D000544
10936886	224	240	apolipoprotein E	Gene	348
10936886	242	246	ApoE	Gene	348
10936886	253	257	ApoJ	Gene	1191
10936886	395	400	Abeta	Gene	351
10936886	514	518	ApoE	Gene	348
10936886	524	528	ApoJ	Gene	1191
10936886	569	574	Abeta	Gene	351
10936886	612	616	ApoE	Gene	348
10936886	659	664	Abeta	Gene	351
10936886	773	792	Alzheimer's disease	Disease	MESH:D000544
10936886	812	817	APOE4	Gene	348
10936886	854	859	APOE2	Gene	348
10936886	Association	1191	351
10936886	Association	348	351
10936886	Association	MESH:D000544	348
10936886	Association	MESH:D000544	1191
10936886	Association	MESH:D000544	351

